Edgestream Partners, L.P. Roivant Sciences Ltd. Transaction History
Edgestream Partners, L.P.
- $2.23 Billion
- Q3 2024
A detailed history of Edgestream Partners, L.P. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 48,226 shares of ROIV stock, worth $561,350. This represents 0.02% of its overall portfolio holdings.
Number of Shares
48,226Holding current value
$561,350% of portfolio
0.02%Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$767 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$766 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$630 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$485 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$412 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.2B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...